Sex Differences in Infectious Diseases

by | Jul 12, 2021 | Coronavirus, COVID-19, Data, FDA, Human Factors, Medicine, Real World Evidence, Women's Health

Women and men are different in many aspects when it comes to disease-causing pathogens. An interesting fact is that these differences are also observed in the risk of contracting and responding to diseases, specifically infectious diseases. A well-known and well-studied example is COVID-19. COVID-19 affects both sexes equally, but it has been observed that men are at a higher risk of dying from the infectious disease than women. This is also true for the outbreaks caused by severe acute respiratory syndrome, or SARS, and the Middle East respiratory syndrome, or MERS.

There are several factors as to why women and men respond differently to infectious diseases. Some of the more common reasons include hormonal factors, social and behavioral factors, exposure to different pathogens, and immune responses against different pathogens. Differences in exposure to different pathogens largely depend on cultural, socioeconomic, immunological, hormonal, and behavioral factors.

Differences in occupational exposures are also a reason for the disparity among genders. Men are more likely to adopt occupations, like mining and farming, which could put them at an increased risk for respiratory disease or a mosquito-borne disease, like malaria. Women also dominate the nursing field in almost all countries around the world, which increases their chances of contracting infectious diseases while caring for their patients.

Sex differences are also a significant challenge in clinical studies. As per regulatory guidelines, women that are of reproductive age are excluded from phase I clinical trials. Many therapies are then approved based on data that is solely gained from clinical studies conducted with all male participants.

Disease severity, susceptibility, and treatment responses are significantly affected by sex-based mechanisms. Considering both sexes in infectious disease research is essential, a better understanding of these relationships and the other mechanisms involved can help improve general health and prevent infectious diseases.

If you need help with any clinical research, regulatory, or compliance aspect of your product, EMMA International’s team of experts has you covered. Contact us at 248-987-4497, or email info@emmainternational.com today!

1News-Medical. (2021, June 22). Sex Differences in Infectious Diseases. News-Medical.net. https://www.news-medical.net/health/Sex-Differences-in-Infectious-Diseases.aspx

Abby McVay

Abby McVay

Research Analyst- Ms. McVay is EMMA International’s Research Analyst. She has experience in technical writing and clinical trials in many life science industries. She has experience with many different elements of quality and regulatory compliance. Ms. McVay holds a Bachelor of Science in Psychology from Manchester University as well as a Master of Science in Industrial and Organizational Psychology from Angelo State University.

More Resources

De Novo Classification

De Novo Classification

A device can be registered for the De Novo pathway if there is evidence of the safety and effectiveness of the device and there is not a previously legally marketed predicate device1. When determining if your device can go through the De Novo process there are two pathways available to determine the device classification.
Abbreviated 510k submission

Abbreviated 510k submission

There are three types of 510K, Premarket Notifications, which can be submitted to the Food and Drug Administration (FDA) traditional, abbreviated, and special. Abbreviated and Special 510K submissions can be utilized when the submissions meet the certain factors presented by the FDA. When submitting an abbreviated 510K the submission must include the elements that are identified in 21CFR 807.87 for the information required in a premarket notification submission.
Is your product a medical device?

Is your product a medical device?

Many marketed products are classified as medical devices and you would not even know it. Medical devices range from latex gloves and tongue depressors to respirators and heart valves. To determine if the product is considered a medical device by the Food and Drug Administration (FDA) you will need to analyze if your product meets the definition of a medical device per the Food, Drug, and Cosmetic Act1.

Ready to learn more about working with us?

Pin It on Pinterest

Share This